Chronic cough, defined as a cough persisting beyond eight weeks, presents a common yet complex clinical challenge. Despite its prevalence, the condition is often under-recognized and inadequately managed, leading to significant patient distress and diminished quality of life.
The etiology of chronic cough is multifactorial, with common causes including gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and asthma. However, it's crucial to note that many patients may present with 'cough-variant' conditions, where cough is the sole or predominant symptom. A thorough history, physical examination, and targeted investigations are therefore paramount in identifying the underlying cause.
Management of chronic cough should be etiology-specific. For instance, GERD-associated cough might respond to proton pump inhibitors, while UACS may require antihistamines or nasal steroids. Inhaled corticosteroids can be beneficial for cough-variant asthma. Additionally, centrally acting therapies, such as gabapentin and amitriptyline, have shown promise for refractory cases. It's essential to regularly follow-up and reassess treatment efficacy.
Given the complexity of chronic cough, a multidisciplinary approach involving pulmonologists, gastroenterologists, allergists, and speech pathologists can often be beneficial. This team can provide comprehensive care, addressing not only the cough but also associated symptoms like laryngeal hypersensitivity, voice changes, and swallowing difficulties.
Chronic cough, while common, remains an enigmatic condition that requires a meticulous, comprehensive approach for effective management. By understanding the multifaceted nature of its causes, adopting an etiology-specific treatment, and incorporating a multidisciplinary team, clinicians can significantly improve patient outcomes and quality of life.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation